QGEN
Qiagen N.V.
$33.04
-1.40%
2026-05-08
About Qiagen N.V.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Key Fundamentals
P/E Ratio
16.36
Forward P/E
12.59
EPS (TTM)
$2.04
ROE
11.9%
Revenue Growth (YoY)
1.8%
Profit Margin
19.2%
Debt/Equity
49.42
Dividend Yield
0.8%
Price/Book
1.82
Beta
0.64
Market Cap
$6.88B
Avg Volume (10D)
2.9M
Recent Breakout Signals
No recent breakout signals detected for QGEN.
Recent Price Range (60 Days)
60D High
$52.20
60D Low
$32.92
Avg Volume
1.8M
Latest Close
$33.04
Get breakout alerts for QGEN
Sign up for Breakout Scanner to receive daily notifications when QGEN triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Qiagen N.V. (QGEN) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors QGEN daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. QGEN operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.